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and its distribution mimics that of normal breast parenchyma [3] . Similarly, sonography has limitations in the diagnosis of invasive lobular carcinoma, especially in detecting small lesions [3, 7] . With the limitations of mammography, sonography, and even MRI in detecting invasive lobular carcinoma, addition al imaging techniques are needed to improve the detection of invasive lobular carcinoma.
Breastspecific gamma imaging (BSGI) is a physiologic, rather than an anatomic, ap proach to breast cancer diagnosis. BSGI uses 99mtechnetium sestamibi and a highreso lution breastspecific gamma camera for the detection of breast cancer. BSGI in the diag nosis of breast cancer is based on the differ ential uptake of radiotracer in cancer cells as compared with in the normal surrounding breast tissue; this increased uptake is thought to be due, in part, to increased vascularity and mitochondrial activity in cancer cells [10] . Although earlier studies investigated the use of a traditional gamma camera for breast imaging, the intrinsic size resolution did not allow reliable detection of subcenti meter and nonpalpable breast cancers. Fur thermore, a traditional gamma camera does not allow imaging the breasts in positions comparable to mammography so that image correlation can more easily be undertaken. The use of a highresolution gamma camera allows the reliable detection of subcentime ter cancers-even those smaller than 5 mm [10] . BSGI has been shown to be reliable re gardless of breast density or pathologic type of breast cancer [11] . With the increasing use of BSGI, our observations have suggested that BSGI may allow the improved detection of invasive lobular carcinoma.
The purpose of this study was to compare the sensitivities of mammography, sonogra phy, MRI, and BSGI in the detection of pure invasive lobular carcinoma.
Materials and Methods

Study Design
Institutional review board approval was ob tained before the beginning of the study as well as a consent waiver. The study was performed as a multicenter retrospective chart review from four institutions: two academic centers and two private practices. All results and data were obtained solely from patients' medical records. Only women with biopsyproven pure invasive lobular carcinoma who also underwent BSGI were eligible for inclusion in the study group. Twentysix women who ranged in age from 46 to 82 years (mean age, 62.8 years) were included. Invasive lobular carci nomas with ductal components were excluded from the study. Surgical pathology reports were obtained to confirm the histopathology.
All patients were imaged with mammography and BSGI. The results of sonography and MRI, if performed, and the pathologic tumor size were included. All radiologists who interpreted the examinations were experienced breast imagers, each with a minimum of 5 years of experience interpreting BSGI. Patients underwent BSGI us ing a highresolution breastspecific gamma cam era (6800 Gamma Camera, Dilon Techno logies) after IV injection of 20-25 mCi (740-925 MBq) of 99m Tc sestamibi (Miraluma, Dupont Pharma) in an antecubital vein. The BSGI camera uses a detector mounted to an articulating arm so that the breast can be imaged in all projections, including those comparable to the positions used in mam mog raphy. Planar images were acquired in the cranio caudal (CC) and mediolateral oblique (MLO) projections for 7-10 minutes per image. The number of counts per image varies from pa tient to patient depending on the uptake of sestamibi in the breast tissue; however, a minimum number of 100,000 counts per image were obtained.
Mammography was performed with the equip ment available at each institution (DMR, GE Healthcare; Diamond Analog, Instrumentarium Imaging; model 300, Siemens Medical Solutions; and M4, Elite, and Sophie, Lorad). Sonography was performed using a highfrequency transducer (12-13 MHz) with the equipment available at each institution (Elegra and Antares, Siemens Medical Solutions; models 5000 and IU22, Philips Health care). MRI was performed with a 1.5T scanner and a dedicated breast coil with and without gadolinium using the standard breast protocol at each institution, which included unenhanced and contrastenhanced T1 images as well as 3D volu metric sequential images after the admini stration of gadolinium. All images were obtained as part of the clinical evaluation of the patients, and imaging was deemed necessary by the refer ring physician, interpreting radiologist, or both.
Data and Statistical Analysis
The results of BSGI studies were classified as positive (focal increased radiotracer uptake) or negative (no focal increased radiotracer uptake or scattered heterogeneous physiologic uptake) by one of four radiologists experienced in all tech niques of breast imaging including BSGI. Like wise, the results of mammography and, when applicable, MRI and sonography were classified as positive or negative for invasive lobular carci noma; any discrepancies were resolved by con sensus. The reports in the patients' medical records were used, and the results of imaging were not reevaluated for this study. The data were analyzed to determine the sensitivities of mam mography, sonography, MRI, and BSGI for the detection of invasive lobular carcinoma. For the reference standard, the final surgical pathology report was used.
The perlesion sensitivities for BSGI, mam mography, sonography, and MRI were determined along with corresponding exact binomial 95% CIs [12] . Estimates of the differences in per lesion sensitivities between BSGI and each imag ing technique-mammography, sonography, and MRI-were determined along with 98 ⅓% CIs for differences in correlated proportions [13] . The three hypotheses that BSGI is more sensitive than each other technique-that is, mammography, sonography, and MRI-were tested using the McNemar test for correlated proportions, pro viding p values that were compared with a significancelevel alpha value of 0.01667. The 98⅓% CIs and alpha value of 0.01667 significance levels were used to protect against multiple comparisons, preserving the overall significance level for the study at an alpha of 0.05. Statistical analyses were performed using statistics software (Intercooled, version 8.0, Stata).
Results
Twentyeight biopsyproven pure invasive lobular carcinomas were detected in the 26 women in the study group; two had bilateral cancers. The mean pathologic size of the inva sive lobular carcinomas was 22.3 mm (range, 2-90 mm). Mammographic findings were neg ative in six cancers. The abnormal mammo graphic findings, seen in 22 of 28 carcinomas, included 13 of 22 (59%) asymmetric densities, four (18%) architectural distortions, and five (23%) spiculated masses. In seven of the 22 pa tients (32%), the invasive lobular carcinoma manifested mammographically as microcalci fications. Mammography had an overall sensi tivity of 79% for invasive lobular carcinoma.
In the 25 patients who underwent sonogra phy, 17 focal hypoechoic areas were detect ed. Eight patients had negative sonography examinations. Tumor size as determined by sonography was available in 17 lesions (mean size, 14 mm; range, 7-32 mm). Of the eight lesions not visualized on sonography, one was also not seen on BSGI; the other lesion missed on BSGI was found on sonography. The sensitivity of sonography for the detec tion of invasive lobular carcinoma was 68%.
Twelve of the 26 patients had MRI exami nations with 10 of 12 (83.3%) lesions enhanc ing after injection of gadolinium including four lesions that were not visualized on mam mography. The mean size of the lesions de tected on MRI was 19.9 mm (range, 2-77 mm). The sensitivity of MRI for the detection of invasive lobular carcinoma was 83%.
Imaging Diagnosis of Invasive Lobular Carcinoma
BSGI showed increased radiotracer uptake in 26 of 28 invasive lobular carcinomas with a sensitivity of 93%. Figure 1 shows a lesion that was detected by all imaging techniques. The mean size of the lesions detected by BSGI was 20.3 mm (range, 2-77 mm). The smallest invasive lobular carcinoma detected with BSGI was 2 mm. Two lesions were not detected on BSGI, measuring 5 and 90 mm, respectively. BSGI detected six cancers that were mammographically occult. Figure 2 shows a lesion that was detected by both MRI and BSGI but that was not detected on mam mography. Two invasive lobular carcinomas were detected with BSGI, whereas the MRI findings were negative. These cancers mea sured 5 and 40 mm, respectively.
The sensitivities of BSGI, mammography, sonography, and MRI and the corresponding 95% exact CIs are provided in Table 1 . BSGI has the highest sensitivity, followed by MRI, mammography, and sonography.
The overall sensitivity of BSGI was com pared with the sensitivities of mammography, sonography, and MRI using the Table 2 . None of the differences in sensitivity was statistically sig nificant at the alpha value of 0.01667 signifi cance level, which preserves an overall alpha value of 0.05 significance level for the study. However, there was a nonsignificant trend for BSGI to have a higher sensitivity for the de tection of invasive lobular carcinoma than mammography, sonography, or MRI.
Discussion
Invasive lobular carcinoma represents nearly 10% of all breast cancer diagnoses and is the second most common breast malignancy. His torically, it has presented a challenge in terms of its detection. It is believed that its elusive na ture on imaging may be attributed to its growth pattern: Invasive lobular carcinoma is a slow growing carcinoma and as it grows it fails to invoke a desmoplastic reaction. Its unique his tology contributes to the difficulty in early de tection, both clinically and radiographically. Studies using BSGI have shown the high sensitivity of this approach for the diagnosis of breast cancer as well as the ability to de tect not only subcentimeter cancers, but also cancers smaller than 5 mm [10] . The possible improvement in detecting a difficulttodiag nose breast cancer-invasive lobular carci noma-with BSGI and the opportunity to compare the sensitivities of three imaging techniques with that of BSGI were the moti vations to undertake this study.
The results of this study show that BSGI has the greatest sensitivity (93%) for detecting in vasive lobular carcinoma followed by MRI (83%), mammography (79%), and so no g raphy (68%). Notably, in six instances in which the cancer was not seen on mammography, BSGI detected invasive lobular carcinoma lesions. In addition, MRI detected four lesions that were missed on mammography. Statistical analysis did not show a statistically significant differ ence in invasive lobular carcinoma detection between BSGI and mammography, sono graphy, or MRI. However, a nonstatistically significant trend toward improved detection us ing BSGI and MRI was seen, but additional and larger studies are needed to further investi gate these trends. BSGI appears to be superior or comparable to MRI in the detection of inva sive lobular carcinoma, but estimates for sensi tivity and comparison of the sensitivities of BSGI and MRI should be interpreted with cau tion because the lesions for which MRI results were not obtained, more than half of the study lesions, may differ substantially from those im aged with MRI.
This study is the first, to our knowledge, to compare the sensitivity of four different breast imaging techniques for the diagnosis of invasive lobular carcinoma. This multiin stitutional study of 26 patients with 28 le sions is limited in the number of patients and invasive lobular carcinoma lesions. However, because invasive lobular carcinoma is an in frequent breast cancer, cases from numerous institutions would be required to obtain a sufficient number of cancers to more exten sively evaluate and compare the different imaging techniques for the diagnosis of in vasive lobular carcinoma. Nevertheless, a larger multiinstitution study including more patients than ours would certainly be of benefit to confirm the comparative sensitivi ties of mammography, sonography, MRI, and BSGI in the diagnosis of invasive lobu lar carcinoma. In addition, differences in sensitivity could be attributed to differences in MRI and sonography technique and equipment as well as to differences in the experience and ability of the interpreting radiologists at the various centers that par ticipated in this study. This study does, however, show the high sensitivity of BSGI for the detection of invasive lobular carci noma. Whether BSGI has a sensitivity that is equal to or greater than that of MRI for the detection of invasive lobular carcinoma awaits additional larger trials.
Both BSGI and MRI are physiologically based imaging techniques, and both use, in part, tumor vascularity to image breast can cer. A recent study comparing BSGI and MRI for the detection of breast cancer showed equal sensitivity and greater speci ficity for BSGI over MRI [14] . However, be yond the greater specificity of BSGI over MRI, BSGI has other advantages. A BSGI examination is performed with the patient sitting comfortably as opposed to being con fined in an MRI scanner and therefore there is no issue of claustrophobia. A BSGI exami nation generates from four to 16 images at Although there has not been, to our knowledge, a study formally comparing the time for interpretation of BSGI versus breast MRI, our clinical experience is that the in terpretation time for a BSGI examination is less than that required for breast MRI. In our practice, the cost of a BSGI examination is less than that of a breast MRI examination. Further costeffectiveness studies will better define the comparative costs of these two studies. Finally, with the increasing concern of renal complications with the administra tion of gadolinium, the IV injection of 99m Tc sestamibi has not been reported to be associ ated with significant complications.
The issue of which technique should be used to biopsy lesions detected with BSGI has been raised. In our practice, we perform secondlook directed sonography in the re gion of the breast showing focal increased radiotracer uptake on BSGI. We can local ize the region based on the quadrant where radiotracer uptake is increased as well as the distance from the nipple. This examina tion is essentially the same as directed sec ondlook sonography after a focal finding is seen on MRI examination. If a lesion is de tected with sonography, then a sonographi cally guided biopsy is performed. If no lesion is identified with careful, directed second look sonography, then an MRI examination can be performed to determine whether an MRIguided minimally invasive breast bi opsy can be performed. Of course, direct gamma imaging-guided minimally inva sive breast biopsy would be optimal and such a device is currently under develop ment. In the near future, direct gamma im aging guidance for minimally invasive breast biopsy should be available.
In summary, our study shows that BSGI has a higher sensitivity (93%) for the detec tion of invasive lobular carcinoma than mammography (79%), MRI (83%), and sono graphy (68%). BSGI should be consid ered in evaluating patients with indetermi nate breast lesions. Additional larger multi institutional studies are needed to further evaluate BSGI's utility in the diagnosis of invasive lobular carcinoma. 
